HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$0.40
Day range
$0.38 - $0.50
Year range
$0.22 - $66.33
Market cap
8.87M USD
Avg Volume
12.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.09M | 24.28% |
Net income | -5.92M | -44.73% |
Net profit margin | — | — |
Earnings per share | -45.93 | 92.68% |
EBITDA | -5.08M | -24.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.81M | 109.97% |
Total assets | 7.29M | 41.10% |
Total liabilities | 9.31M | 163.91% |
Total equity | -2.02M | — |
Shares outstanding | 23.34M | — |
Price to book | -0.20 | — |
Return on assets | -226.72% | — |
Return on capital | 14,483.80% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.92M | -44.73% |
Cash from operations | -3.15M | 44.45% |
Cash from investing | -500.00 | — |
Cash from financing | 7.08M | 624.02% |
Net change in cash | 3.94M | 183.99% |
Free cash flow | -1.84M | 54.14% |
About
Founded
2016
Headquarters
Website
Employees
7
